Wegovy (semaglutide) is a self-injectable prescription weight loss medicine that has helped ... 46% over two years for patients trying GLP-1 drugs for obesity, from $12,695 to $18,507.
Such is the appetite for GLP-1 drugs that Danish Wegovy manufacturer Novo Nordisk has become Europe’s most valuable company, with a market capitalisation of around $600bn. So, where does that leave ...